44,446 Shares in CVS Health Co. (NYSE:CVS) Acquired by Eagle Asset Management Inc.

Eagle Asset Management Inc. acquired a new stake in shares of CVS Health Co. (NYSE:CVS) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 44,446 shares of the pharmacy operator’s stock, valued at approximately $2,795,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Charles Schwab Investment Management Inc. raised its holdings in shares of CVS Health by 2.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 12,208,668 shares of the pharmacy operator’s stock worth $767,681,000 after purchasing an additional 304,386 shares during the period. Pacer Advisors Inc. lifted its position in CVS Health by 2.6% during the third quarter. Pacer Advisors Inc. now owns 633,045 shares of the pharmacy operator’s stock valued at $39,806,000 after buying an additional 15,889 shares in the last quarter. Integrated Investment Consultants LLC purchased a new stake in CVS Health during the third quarter worth approximately $1,013,000. Cypress Capital Group increased its position in shares of CVS Health by 5.1% in the third quarter. Cypress Capital Group now owns 6,654 shares of the pharmacy operator’s stock worth $418,000 after acquiring an additional 320 shares in the last quarter. Finally, Landscape Capital Management L.L.C. raised its stake in shares of CVS Health by 45.4% in the 3rd quarter. Landscape Capital Management L.L.C. now owns 75,524 shares of the pharmacy operator’s stock valued at $4,749,000 after acquiring an additional 23,594 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts recently issued reports on CVS shares. Barclays lowered their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a report on Thursday, November 7th. Truist Financial reiterated a “buy” rating and set a $67.00 target price (down from $76.00) on shares of CVS Health in a report on Wednesday, November 20th. Wells Fargo & Company upgraded CVS Health from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $60.00 to $66.00 in a report on Monday, November 18th. Evercore ISI lifted their price objective on shares of CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. Finally, StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $70.33.

CVS Health Stock Performance

CVS stock opened at $60.10 on Tuesday. The firm has a market cap of $75.63 billion, a P/E ratio of 15.25, a P/E/G ratio of 0.98 and a beta of 0.55. The stock’s 50 day simple moving average is $59.25 and its 200 day simple moving average is $58.67. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12-month low of $52.71 and a 12-month high of $83.25.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. During the same period last year, the firm posted $2.21 EPS. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. As a group, equities research analysts predict that CVS Health Co. will post 5.43 EPS for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.43%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s payout ratio is 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.